FOR IMMEDIATE RELEASE

 

Company Contact:                                                       Investor Relations

Paul A. Brown, M.D, Founder & Chairman                        Scott Liolios or Ron Both

Stephen J. Hansbrough, President & CEO                       Liolios Group, Inc.          
HearUSA, Inc                                                                info@liolios.com

(561) 478-8770                                                               (949) 574-3860  

                                                                                                 

 

HEARUSA REPORTS RECORD THIRD QUARTER 2007 RESULTS

 

Net Revenues Reach Fourth Consecutive Record Quarter High

Net Revenues at $26.9 Million, up 22% vs. Year Ago Quarter

Net Income at Record $488,000 or $0.01 per share

Net Income from Operations at Record $2.5 million or 9.3% of Revenues

 

West Palm Beach, Fla. -- November 13, 2007 -- HearUSA, Inc. (AMEX: EAR), a leading provider of hearing care through a fully integrated and professionally accredited system of hearing care centers, reported financial results for the third quarter ended September 29, 2007. 

 

Net revenues totaled a record $26.9 million, an increase of 8% from $24.9 million in the previous quarter and an increase of 22% from $22.0 million in the comparable quarter of the previous year. This fourth consecutive quarter of record net revenues was attributable to a combination of hearing centers acquired within the last 12 months and organic growth of 7% for the quarter.

 

Income from operations was a record $2.5 million or 9.3% of revenues, as compared to $810,000 or 3.0% of revenues in the previous quarter and $405,000 or 1.8% of net revenues a year ago. These substantially improved results come very close to the company’s stated long term objective for income from operations to be in the range of 10% to 12%. It should be noted that income from operations includes a one-time charge of $282,000 related to employee severance applicable to the third quarter.

 

The net income applicable to common stockholders for the third quarter was a record $488,000 or $0.01 per share, as compared to a net loss of $3.4 million or $0.09 per share in the previous quarter and net loss of $1.7 million or $0.05 per share in the comparable quarter of the previous year.

 

HearUSA acquired eight hearing care centers during the quarter, with combined estimated trailing twelve-month ("TTM") revenues of $2.8 million. This brings the total number of acquisitions for the first nine months of 2007 to 14, with combined estimated TTM revenues of $6.9 million. At the end of the quarter, the company had 12 letters of intent for the acquisition of an additional 17 centers with approximately $7.8 million TTM revenues.

 

“A combination of healthy organic growth and our continued aggressive acquisition program led to a record quarter for both revenues and income for HearUSA,” said Stephen J. Hansbrough, president and CEO. “We are especially pleased with the strong organic growth we enjoyed in the quarter as it reflects both the success of the Don Shula marketing campaign and our continued position as the provider of choice for hearing care to the nation’s top managed healthcare organizations.”

 

“It’s also important to note that this quarter, while a record in net income, still does not reflect the positive impact of our previously announced plan to reduce corporate expenses by more than $1 million by the end of the third quarter,” added Hansbrough. “This quarter’s performance keeps us on track to meet or exceed our stated goals for 2007, which include both improved profitability and an increase in net revenues of 15-20% over last year.”

 

Conference Call

The company will hold a conference call later today to discuss its third quarter financial results. President and CEO Stephen J. Hansbrough and Executive Vice President and CFO Gino Chouinard will host the presentation, which will be followed by a question and answer period.

 

Date: Tuesday, November 13, 2007

Time: 4:30 pm Eastern (1:30 pm Pacific)

Toll Free Dial-In Number: 1-877-407-9210

International/Toll Dial-in Number: 1-201-689-8049

Conference ID Number: 261662

            Internet Simulcast: http://www.vcall.com/IC/CEPage.asp?ID=123001

 

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization and ask you to wait until the call begins. If you have any difficulty connecting with the conference call, please contact the Liolios Group at (949) 574-3860.

 

A replay of the call will be available later that evening and accessible until November 27, 2007.

 

Toll-free Replay Number: 1-877-660-6853
International/Toll Replay Number: 1-201-612-7415
Conference ID Number: 261662; Account Number: 286

Internet Replay: http://www.vcall.com/IC/CEPage.asp?ID=123001

 

About HearUSA

HearUSA, Inc. provides hearing care to patients primarily through more than 175 company-owned hearing care centers, which offer a complete range of quality hearing aids with an emphasis on the latest digital technology. HearUSA Centers are located in California, Florida, New York, New Jersey, Massachusetts, Ohio, Michigan, Missouri and the province of Ontario, Canada. The company also derives revenues from its HearUSA Hearing Care Network, comprised of  over 1,600 affiliated audiologists in 49 states, as well as its website that enables online purchases of hearing related products, such as batteries, hearing aid accessories and assistive listening devices. For further information, click on "investor information" at the HearUSA website: www.hearusa.com.

 

Forward Looking Statements 

This press release contains forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995, including those concerning the company being on track to meet or exceed the stated goals for 2007 including improved profitability and an increase in net revenues of 15-20% over 2006These statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Potential risks and uncertainties include such factors as successful implementation of the company’s acquisition program; integration of the newly acquired centers and maintenance of revenue levels from those centers; the  company’s ability to maintain cost controls and limit expenses; the successful implementation of the Siemens agreements; the ability of the company to maintain unit sales of Siemens hearing aids; market demand for the company’s goods and services; changes in the pricing environment; general economic conditions in those geographic regions where the company’s centers are located; the impact of competitive products; and other risks and uncertainties described in the company’s filings with the Securities and Exchange Commission, including the company’s Form 10-K for the fiscal year ended December 30, 2006. 


 HearUSA, Inc.

Consolidated Balance Sheets

 (unaudited)

 

 

September 29,

December 30,

ASSETS

2007

2006

 

(Dollars in thousands)

Current assets

 

 

Cash and cash equivalents  

$                3,526

$                2,326

Accounts and notes receivable, less allowance for

 

 

   doubtful accounts of $505,497 and $434,098

8,851

7,591

Inventories

2,209

2,371

Prepaid expenses and other

986

1,400

Deferred tax asset

78

67

Total current assets

15,650

13,755

Property and equipment, net

4,176

3,878

Goodwill

57,465

50,970

Intangible assets, net 

15,766

13,592

Deposits and other

705

876

Restricted cash and cash equivalents

209

205

Total Assets

$              93,971

$              83,276

 

LIABILITIES AND STOCKHOLDERS’  EQUITY

 

Current liabilities

 

 

Accounts payable

$              11,016

$              10,463

Accrued expenses

2,929

2,509

Accrued compensation

3,069

2,826

Current maturities of long-term debt

6,471

8,391

Current maturities of convertible subordinated notes, net of debt discount of $1,263,003 in 2006

-

2,487

Current maturities of subordinated notes, net of debt discount of $134,169 and $452,228

1,845

1,308

Dividends payable

34

34

Minority interest in net income of consolidated joint venture, currently payable

820

633

Total current liabilities

26,184

28,651

Long-term debt

37,252

28,599

Deferred income taxes

5,948

5,234

Convertible subordinated notes, net of debt discount of $217,923 in 2006 

-

2,282

Subordinated notes, net of debt discount of $60,123 in 2006 

-

1,480

Warrant liability

-

110

Total long-term liabilities

43,200

37,705

Commitments and contingencies

-

-

 

 

 

Stockholders’ equity

 

 

Preferred stock (aggregate liquidation preference $2,330,000, $1 par, 7,500,000 shares authorized)

 

 

Series H Junior Participating (none outstanding)

-

-

Series J (233 shares outstanding)

-

-

Total preferred stock

-

                -

 

 

 

Common stock: $.10 par; 75,000,000 shares authorized

37,870,451 and 32,029,750 shares issued

3,787

3,203

Stock subscription

(412)

(412)

Additional paid-in capital

132,499

123,972

Accumulated deficit

(112,977)

 (109,521)

Accumulated other comprehensive income

4,175

2,163

Treasury stock, at cost:523,662 common shares

(2,485)

(2,485)

Total Stockholders’ Equity

24,587

16,920

Total Liabilities and Stockholders’ Equity

$              93,971

$              83,276

 


HearUSA, Inc.

Consolidated Statements of Operations

Three Months Ended September 29, 2007 and September 30, 2006

(unaudited)

 

 

September 29,

September 30,

 

2007

2006

 

(Dollars in thousands, except per share amounts)

 

 

 

Net revenues

 

 

Hearing aids and other products

$              25,050

$              20,519

Services

1,812

1,523

Total net revenues

26,862

22,042

 

 

 

Operating costs and expenses

 

 

Hearing aids and other products

6,807

6,491

Services

499

511

Total cost of products sold and services

7,306

7,002

Center operating expenses

12,585

10,598

General and administrative expenses

3,890

3,540

Depreciation and amortization

572

497

Total operating costs and expenses

24,353

21,637

Income from operations

2,509

405

Non-operating income (expenses):

 

 

Gain from insurance proceeds

-

146

Interest income

21

19

Interest expense

(1,330)

(1,638)

Income (loss) before income tax expense and minority interest in income of consolidated joint venture 

1,200

(1,068)

Income tax expense

(284)

(257)

Minority interest in income of consolidated joint venture

(394)

(322)

Net income (loss)

522

(1,647)

Dividends on preferred stock

(34)

(34)

Net income (loss) applicable to common stockholders

$                   488

$             (1,681)

 

 

 

Net income (loss) applicable to common stockholders per common share – basic

$                  0.01

$               (0.05)  

Net income (loss) applicable to common stockholders per common share –diluted

$                  0.01

$               (0.05)  

 

 

 

Weighted average number of shares of common stock outstanding – basic

37,950

32,260

Weighted average number of shares of common stock outstanding – diluted

46,415

32,260

 

 

 

###